Reuters is reporting that in 2015, the number of drug approvals surpassed the 18-year high that 2014 saw. But the number of approvals is being accompanied by a decline in the return on companies' research and development investements, as returns have dropped to 4.2%, less than half of the 10% reported in 2010. (Reuters)
The drug blocks ALK protein activity in an effort to prevent the spread of cancer cells. About 5% of patients with NSCLC develop ALK gene mutations, which make it possible for the cancer to spread to a patient’s brain.
The NCPA pointed out that its recent survey of pharmacists found that from their perspective, generic price spikes have gotten worst since they last conducted a survey in 2013 and are affecting both pharmacists and patients.
Getting 65% of Americans to manage their high levels of LDL cholesterol by 2017 is one of the major targets of the U.S. Department of Health and Human Services’ Million Hearts initiative to prevent one million heart attacks and strokes.
In the letter NACDS sent to all U.S. Senators earlier this week, the association cited the differences in active ingredients in drugs from other countries, as well as different shapes, sizes and colors, which can cause confusion for patients and healthcare professionals.